|
Diabetes, Vol 48, Issue 4 881-889, Copyright © 1999 by American Diabetes Association
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy
P Fernyhough, A Gallagher, SA Averill, JV Priestley, L Hounsom, J Patel and DR Tomlinson
Division of Neuroscience, School of Biological Sciences, University of Manchester, UK. paul.fernyhough@man.ac.uk
Aberrant neurofilament phosphorylation occurs in many neurodegenerative
diseases, and in this study, two animal models of type 1 diabetes--the
spontaneously diabetic BB rat and the streptozocin-induced diabetic
rat--have been used to determine whether such a phenomenon is involved in
the etiology of the symmetrical sensory polyneuropathy commonly associated
with diabetes. There was a two- to threefold (P < 0.05) elevation of
neurofilament phosphorylation in lumbar dorsal root ganglia (DRG) of
diabetic rats that was localized to perikarya of medium to large neurons
using immunocytochemistry. Additionally, diabetes enhanced neurofilament M
phosphorylation by 2.5-fold (P < 0.001) in sural nerve of BB rats.
Neurofilaments are substrates of the mitogen-activated protein kinase
(MAPK) family, which includes c-jun NH2-terminal kinase (JNK) or
stress-activated protein kinase (SAPK1) and extracellular signal-regulated
kinases (ERKs) 1 and 2. Diabetes induced a significant three- to fourfold
(P < 0.05) increase in phosphorylation of a 54-kDa isoform of JNK in DRG
and sural nerve, and this correlated with elevated c-Jun and neurofilament
phosphorylation. In diabetes, ERK phosphorylation was also increased in the
DRG, but not in sural nerve. Immunocytochemistry showed that JNK was
present in sensory neuron perikarya and axons. Motoneuron perikarya and
peroneal nerve of diabetic rats showed no evidence of increased
neurofilament phosphorylation and failed to exhibit phosphorylation of JNK.
It is hypothesized that in sensory neurons of diabetic rats, aberrant
phosphorylation of neurofilament may contribute to the distal sensory
axonopathy observed in diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Wang, B. Nadarajah, A. C. Robinson, B. W. McColl, J.-W. Jin, F. Dajas-Bailador, R. P. Boot-Handford, and C. Tournier
Targeted Deletion of the Mitogen-Activated Protein Kinase Kinase 4 Gene in the Nervous System Causes Severe Brain Developmental Defects and Premature Death
Mol. Cell. Biol.,
November 15, 2007;
27(22):
7935 - 7946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Daulhac, C. Mallet, C. Courteix, M. Etienne, E. Duroux, A.-M. Privat, A. Eschalier, and J. Fialip
Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N-Methyl-D-aspartate-Dependent Mechanisms
Mol. Pharmacol.,
October 1, 2006;
70(4):
1246 - 1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C.M. Ho, K. S.L. Lam, Y. S. Chen, J. C.W. Yip, M. Arvindakshan, S.-I. Yamagishi, S. Yagihashi, P. J. Oates, C. A. Ellery, S. S.M. Chung, et al.
Aldose Reductase-Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage.
Diabetes,
July 1, 2006;
55(7):
1946 - 1953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhou, B. K. Deo, K. Hosoya, T. Terasaki, I. G. Obrosova, F. C. Brosius III, and A. K. Kumagai
Increased JNK Phosphorylation and Oxidative Stress in Response to Increased Glucose Flux through Increased GLUT1 Expression in Rat Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3403 - 3410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Uehara, S.-I. Yamagishi, S. Otsuki, S. Chin, and S. Yagihashi
Effects of Polyol Pathway Hyperactivity on Protein Kinase C Activity, Nociceptive Peptide Expression, and Neuronal Structure in Dorsal Root Ganglia in Diabetic Mice
Diabetes,
December 1, 2004;
53(12):
3239 - 3247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Zochodne, H.-S. Sun, C. Cheng, and J. Eyer
Accelerated diabetic neuropathy in axons without neurofilaments
Brain,
October 1, 2004;
127(10):
2193 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Endocr. Rev.,
August 1, 2004;
25(4):
612 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Brussee, F. A. Cunningham, and D. W. Zochodne
Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy
Diabetes,
July 1, 2004;
53(7):
1824 - 1830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Price, S. Agthong, A. B. Middlemas, and D. R. Tomlinson
Mitogen-Activated Protein Kinase p38 Mediates Reduced Nerve Conduction Velocity in Experimental Diabetic Neuropathy: Interactions With Aldose Reductase
Diabetes,
July 1, 2004;
53(7):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko
Diabetic Somatic Neuropathies
Diabetes Care,
June 1, 2004;
27(6):
1458 - 1486.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Obrosova, F. Li, O. I. Abatan, M. A. Forsell, K. Komjati, P. Pacher, C. Szabo, and M. J. Stevens
Role of Poly(ADP-Ribose) Polymerase Activation in Diabetic Neuropathy
Diabetes,
March 1, 2004;
53(3):
711 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Sayers, L. J. Beswick, A. Middlemas, N. A. Calcutt, A. P. Mizisin, D. R. Tomlinson, and P. Fernyhough
Neurotrophin-3 Prevents the Proximal Accumulation of Neurofilament Proteins in Sensory Neurons of Streptozocin-Induced Diabetic Rats
Diabetes,
September 1, 2003;
52(9):
2372 - 2380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-J. Huang, S. A. Price, L. Chilton, N. A. Calcutt, D. R. Tomlinson, A. Verkhratsky, and P. Fernyhough
Insulin Prevents Depolarization of the Mitochondrial Inner Membrane in Sensory Neurons of Type 1 Diabetic Rats in the Presence of Sustained Hyperglycemia
Diabetes,
August 1, 2003;
52(8):
2129 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Middlemas, J.-D. Delcroix, N. M. Sayers, D. R. Tomlinson, and P. Fernyhough
Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3
Brain,
July 1, 2003;
126(7):
1671 - 1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Xia, E. A. Roberts, L.-S. Her, X. Liu, D. S. Williams, D. W. Cleveland, and L. S.B. Goldstein
Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A
J. Cell Biol.,
April 14, 2003;
161(1):
55 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Akbarzadeh, H. Ji, D. Frecklington, N. Marmy-Conus, Y.-F. Mok, L. Bowes, L. Devereux, M. Linsenmeyer, R. J. Simpson, and D. S. Dorow
Mixed Lineage Kinase 2 Interacts with Clathrin and Influences Clathrin-coated Vesicle Trafficking
J. Biol. Chem.,
September 20, 2002;
277(39):
36280 - 36287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kishi, J. Tanabe, J. D. Schmelzer, and P. A. Low
Morphometry of Dorsal Root Ganglion in Chronic Experimental Diabetic Neuropathy
Diabetes,
March 1, 2002;
51(3):
819 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. PURVES, A. MIDDLEMAS, S. AGTHONG, E. B. JUDE, A. J. M. BOULTON, P. FERNYHOUGH, and D. R. TOMLINSON
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy
FASEB J,
November 1, 2001;
15(13):
2508 - 2514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE
Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
FASEB J,
August 1, 2000;
14(11):
1548 - 1558.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J Brownlees, A Yates, N. Bajaj, D Davis, B. Anderton, P. Leigh, C. Shaw, and C. Miller
Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3
J. Cell Sci.,
January 2, 2000;
113(3):
401 - 407.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, S. B. Plurad, C. A. Parvin, and M. S. Miller
Insulin-like Growth Factor I Reverses Experimental Diabetic Autonomic Neuropathy
Am. J. Pathol.,
November 1, 1999;
155(5):
1651 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-D. Delcroix, S. Averill, K. Fernandes, D. R. Tomlinson, J. V. Priestley, and P. Fernyhough
Axonal Transport of Activating Transcription Factor-2 Is Modulated by Nerve Growth Factor in Nociceptive Neurons
J. Neurosci.,
September 15, 1999;
19(18):
RC24 - RC24.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|